Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects

This study compared the pharmacokinetic and glucodynamic profiles of biosimilar SAR341402 insulin aspart to Japan-approved insulin aspart (NovoRapid) in healthy Japanese males. In this single-center, randomized, double-blind, single-dose, two-period, crossover study, subjects received 0.3 U/kg of SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiramoto, Masanari, Yoshihara, Tatsuya, Schmider, Wolfgang, Takagi, Hiroki, Nowotny, Irene, Kajiwara, Miyuki, Muto, Hideya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617249/
https://www.ncbi.nlm.nih.gov/pubmed/34824344
http://dx.doi.org/10.1038/s41598-021-02410-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617249/
https://www.ncbi.nlm.nih.gov/pubmed/34824344
http://dx.doi.org/10.1038/s41598-021-02410-z

Ejemplares similares